NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38601
Issuer: Liquidia Technologies Inc
Exchange: The Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 419 Davis Drive
Morrisville,
NORTH CAROLINA
27560
Telephone number: 919-328-4400
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Common Stock
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
x 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o  Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
o  Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements for the Securities Exchange Act of 1934, The Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2020-11-18ByTara PettaDirector
Date NameTitle
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Liquidia Charts.
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Liquidia Charts.

Liquidia Technologies Inc News

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
Tuesday 7 May 2024 (14 hours ago) • GlobeNewswire Inc.
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
Tuesday 7 May 2024 (15 hours ago) • GlobeNewswire Inc.
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
Tuesday 30 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
Thursday 25 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 19 January 2024 (4 months ago) • Edgar (US Regulatory)

More Liquidia Technologies Inc News Articles